OTCMKTS:NLBS NutraLife BioSciences (NLBS) Stock Price, News & Analysis → Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad) Free NLBS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$18,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get NutraLife BioSciences alerts: Email Address Ad InvestorPlaceForget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details. About NutraLife BioSciences Stock (OTCMKTS:NLBS)NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.Read More Ad InvestorPlaceForget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details. NLBS Stock News HeadlinesApril 6, 2023 | finance.yahoo.comPressure BioSciences and NutraLife Biosciences Renew Partnership for Development and Distribution of Next Generation NutraceuticalsFebruary 26, 2023 | benzinga.comEnsysce Biosciences Stock (NASDAQ:ENSC), Quotes and News SummaryApril 17, 2024 | InvestorPlace (Ad)Forget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.February 22, 2023 | finance.yahoo.comMBX Biosciences to Participate in the SVB Securities Global Biopharma ConferenceFebruary 18, 2023 | markets.businessinsider.comHere's what Wall Street expects from Pacific Biosciences of California's earningsOctober 27, 2022 | finance.yahoo.comNutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution AgreementSeptember 2, 2022 | usnews.comKansas City University of Medicine and BiosciencesAugust 22, 2022 | finance.yahoo.comNutraLife BioSciences, Inc. (NLBS)April 17, 2024 | InvestorPlace (Ad)Forget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.July 8, 2022 | finanznachrichten.deEmergent Health Corp.: Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate UpdateJuly 8, 2022 | apnews.comEmergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate UpdateJuly 8, 2022 | finance.yahoo.comNutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet ProJune 15, 2022 | finance.yahoo.comNutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional InvestorsMarch 2, 2022 | uk.investing.comNutralife Biosciences Inc (NLBS)February 25, 2022 | benzinga.comNutraLife Biosciences (OTC: NLBS) Reports Expansion With CRP Partnership Agreement As It Prepares For OTCQB UplistingFebruary 7, 2022 | seekingalpha.comNutraLife Biosciences collaborates with CRP; prepares for OTCQB up-listingFebruary 6, 2022 | finance.yahoo.comNutraLife Biosciences Signs Partnership Agreement with CRP & Prepares for OTCQB UplistingFebruary 1, 2022 | seekingalpha.comNutraLife Biosciences announces partnership with Cookies Licensed Retail ProductsFebruary 1, 2022 | finance.yahoo.comNutraLife Biosciences Signs Partnership Agreement with Cookies Licensed Retail Products & Prepares for OTCQB UplistingJanuary 27, 2022 | yahoo.comNutraLife Biosciences, inc. to Webcast Live at VirtualInvestorConferences.com February 3rdDecember 19, 2021 | nz.finance.yahoo.comOmicron: 'The good news is that we have the tools,' doctor saysDecember 19, 2021 | au.finance.yahoo.comFeedbackFruits Wins Two Awards at the Reimagine Education AwardsDecember 17, 2021 | finance.yahoo.comNutraLife Biosciences Partners with KOR Medical to Create Cannabinoid-Based Wellness ProductsJuly 22, 2021 | sg.finance.yahoo.comWe discussed ousting Johnson, ex-adviser to UK prime minister saysSee More Headlines Receive NLBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NutraLife BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dairy products Sub-IndustryN/A Current SymbolOTCMKTS:NLBS CUSIPN/A CIK1563463 Webwww.nutralifebiosciences.com Phone(888) 509-8901Fax954-775-0831Employees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$630,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares180,606,000Free Float118,189,000Market Cap$18,000.00 OptionableNot Optionable Beta-1.01 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Edgar Ward (Age 52)Founder, President, CEO & Director Comp: $350kMr. Nicholas E WardProject & Operations ManagerDr. Kenneth L Duchin Ph.D.Chief Clinical DeveloperDr. Hongxiang Hui M.D.Ph.D., Chief Medical Advisor & Member of Advisory BoardKey CompetitorsImageWorksOTCMKTS:IWKSMedifocusOTCMKTS:MDFZFViewRayNASDAQ:VRAYQAllied Healthcare ProductsNASDAQ:AHPIBohai Pharmaceuticals GroupOTCMKTS:BOPHView All Competitors NLBS Stock Analysis - Frequently Asked Questions How do I buy shares of NutraLife BioSciences? Shares of NLBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NLBS) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe “Perfect Storm” for GoldGold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsAI healthcare stock poised for 36,996% growth?Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressNew Trump BombshellThe Freeport SocietyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NutraLife BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.